November 2017 FDA Recall Valsartan by Prinston Pharmaceutical Inc
D-0209-2018 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Prinston Pharmaceutical Inc on November 29, 2017 for the product Valsartan. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0209-2018

Reason for Recall
Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.
Initiated
11-29-2017
Reported
01-17-2018
Quantity
21,987 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Prinston Pharmaceutical Inc
Nationwide in the USA and Puerto Rico
Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512, USA; NDC 43547-369-09.

Batch or Lot Expiration Information

Lot# : 343B17025, Exp 03/31/19